242 related articles for article (PubMed ID: 34790617)
21. The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation.
Charest G; McBride M; Thomas AK; Manway M; DiCaudo DJ
Cureus; 2023 Sep; 15(9):e44805. PubMed ID: 37809113
[TBL] [Abstract][Full Text] [Related]
22. [Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma].
Wang F; Zhang GH; Ding KY; Liu L; Weng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):663-8. PubMed ID: 26117013
[TBL] [Abstract][Full Text] [Related]
23. Angioimmunoblastic T-Cell Lymphoma: A Case Report.
Miles B; Bazuaye-Ekwuyasi EA; Mallick J; Nguyen QD
Cureus; 2022 May; 14(5):e25526. PubMed ID: 35800798
[TBL] [Abstract][Full Text] [Related]
24. Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma.
Kim TY; Min GJ; Jeon YW; Park SS; Park S; Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Front Oncol; 2021; 11():797028. PubMed ID: 35087758
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.
Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T
Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
27. [Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type associated with diffuse large B-cell lymphoma: a clinicopathological study].
Wang GN; Zhao WG; Zhang DD; Zhang YP; Liu EJ; Lu SS; Li WC
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):918-923. PubMed ID: 37670621
[No Abstract] [Full Text] [Related]
28. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Poon F; Ieremia E; Collins G; Matin RN
Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749
[TBL] [Abstract][Full Text] [Related]
29. Aberrant CD20 expression in angioimmunoblastic T-cell lymphoma.
Tachibana T; Tomita N; Furuya M; Yamanaka S; Takeuchi K; Nakamura N; Fujita H; Ishigatsubo Y
Intern Med; 2011; 50(5):495-9. PubMed ID: 21372466
[TBL] [Abstract][Full Text] [Related]
30. A Rare Case of Angioimmunoblastic T-Cell Lymphoma with Epstein-Barr Virus-Negative Reed-Sternberg-Like B-Cells, Chylous Ascites, and Chylothorax.
Willemsen M; Dielis AWJH; Samarska IV; Koster A; van Marion AM
Case Rep Hematol; 2017; 2017():1279525. PubMed ID: 28487786
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma.
Chen Y; Zheng X; Chen B; Yang X; Zheng J; Zheng Z; Yang T; Liu T; Hu J
Leuk Lymphoma; 2017 Oct; 58(10):2349-2355. PubMed ID: 28306367
[TBL] [Abstract][Full Text] [Related]
32. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
[TBL] [Abstract][Full Text] [Related]
33. Angioimmunoblastic T cell lymphomas: frequent cutaneous skin lesions and absence of human herpes viruses.
Yoon GS; Choi YK; Bak H; Kim BJ; Kim MN; Choi J; Rheu HM; Huh J; Choi JH; Chang SE
Ann Dermatol; 2009 Feb; 21(1):1-5. PubMed ID: 20548847
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas.
Chen YP; Jones D; Chen TY; Chang KC
Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328
[TBL] [Abstract][Full Text] [Related]
35. Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation?
Moonim MT; Nasir A; Hubbard J; Ketley N; Fields P
Int J Surg Pathol; 2017 Jun; 25(4):326-332. PubMed ID: 27913781
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K
Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976
[TBL] [Abstract][Full Text] [Related]
37. The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma.
Peng Y; Yan H; Wang J; Zhang M; He J
Acta Biochim Pol; 2022 Jul; 69(3):559-565. PubMed ID: 35878052
[TBL] [Abstract][Full Text] [Related]
38. Is triple-positive serology for Epstein-Barr virus (VCA-IgG, VCA-IgM, EBNA-IgG) a specific feature of angioimmunoblastic T-cell lymphoma?
Facchinelli D; Parisi A; Krampera M; Veneri D
Tumori; 2020 Oct; 106(5):424-426. PubMed ID: 31634059
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of Epstein-Barr virus-specific antigen peptide-activated cytotoxic T-cells treatment for refractory or recurrent angioimmunoblastic T-cell lymphoma: A prospective clinical observational study.
Bingjie W; Lihong W; Yongjin S; Huihui L; Jinping O; Xi'nan C
Hematol Oncol; 2020 Aug; 38(3):272-276. PubMed ID: 32083758
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
